Deutsche Bank’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,392
| Closed | -$83K | – | 4329 |
|
|
2022
Q1 | $83K | Sell |
4,392
-503
| -10% | -$7.91K | ﹤0.01% | 3645 |
|
|
2021
Q4 | $87K | Sell |
4,895
-624
| -11% | -$18.7K | ﹤0.01% | 3759 |
|
|
2021
Q3 | $204K | Buy |
5,519
+190
| +4% | +$8.43K | ﹤0.01% | 3559 |
|
|
2021
Q2 | $317K | Buy |
5,329
+929
| +21% | +$56.3K | ﹤0.01% | 3511 |
|
|
2021
Q1 | $295K | Buy |
4,400
+635
| +17% | +$49.7K | ﹤0.01% | 3425 |
|
|
2020
Q4 | $228K | Buy |
3,765
+1,211
| +47% | +$82.7K | ﹤0.01% | 3398 |
|
|
2020
Q3 | $202K | Buy |
2,554
+228
| +10% | +$18.2K | ﹤0.01% | 3210 |
|
|
2020
Q2 | $145K | Sell |
2,326
-439
| -16% | -$25.6K | ﹤0.01% | 3278 |
|
|
2020
Q1 | $146K | Sell |
2,765
-2,357
| -46% | -$234K | ﹤0.01% | 3098 |
|
|
2019
Q4 | $618K | Buy |
5,122
+3,999
| +356% | +$575K | ﹤0.01% | 2626 |
|
|
2019
Q3 | $203K | Sell |
1,123
-1,214
| -52% | -$171K | ﹤0.01% | 3185 |
|
|
2019
Q2 | $301K | Sell |
2,337
-1,278
| -35% | -$229K | ﹤0.01% | 3590 |
|
|
2019
Q1 | $879K | Buy |
3,615
+367
| +11% | +$97.1K | ﹤0.01% | 3070 |
|
|
2018
Q4 | $617K | Sell |
3,248
-5,980
| -65% | -$1.46M | ﹤0.01% | 3195 |
|
|
2018
Q3 | $3.03M | Buy |
9,228
+1,136
| +14% | +$348K | ﹤0.01% | 2578 |
|
|
2018
Q2 | $2.52M | Sell |
8,092
-820
| -9% | -$250K | ﹤0.01% | 2803 |
|
|
2018
Q1 | $2.17M | Buy |
8,912
+1,335
| +18% | +$375K | ﹤0.01% | 2809 |
|
|
2017
Q4 | $2.29M | Buy |
7,577
+4,513
| +147% | +$1.26M | ﹤0.01% | 2630 |
|
|
2017
Q3 | $810K | Sell |
3,064
-5,657
| -65% | -$1.64M | ﹤0.01% | 3160 |
|
|
2017
Q2 | $2.3M | Buy |
8,721
+6,985
| +402% | +$1.75M | ﹤0.01% | 2471 |
|
|
2017
Q1 | $623K | Sell |
1,736
-192
| -10% | -$59.4K | ﹤0.01% | 2957 |
|
|
2016
Q4 | $555K | Buy |
1,928
+1,123
| +140% | +$348K | ﹤0.01% | 3110 |
|
|
2016
Q3 | $272K | Sell |
805
-2,422
| -75% | -$885K | ﹤0.01% | 3488 |
|
|
2016
Q2 | $1.37M | Buy |
3,227
+1,192
| +59% | +$491K | ﹤0.01% | 2662 |
|
|
2016
Q1 | $649K | Sell |
2,035
-145
| -7% | -$49.5K | ﹤0.01% | 3064 |
|
|
2015
Q4 | $1.13M | Buy |
2,180
+1,420
| +187% | +$524K | ﹤0.01% | 2793 |
|
|
2015
Q3 | $221K | Buy |
760
+74
| +11% | +$26.3K | ﹤0.01% | 3754 |
|
|
2015
Q2 | $268K | Sell |
686
-628
| -48% | -$222K | ﹤0.01% | 3740 |
|
|
2015
Q1 | $396K | Buy |
1,314
+506
| +63% | +$124K | ﹤0.01% | 3437 |
|
|
2014
Q4 | $179K | Sell |
808
-1,302
| -62% | -$269K | ﹤0.01% | 4366 |
|
|
2014
Q3 | $488K | Buy |
2,110
+590
| +39% | +$149K | ﹤0.01% | 3519 |
|
|
2014
Q2 | $335K | Buy |
1,520
+770
| +103% | +$171K | ﹤0.01% | 3781 |
|
|
2014
Q1 | $235K | Buy |
750
+411
| +121% | +$131K | ﹤0.01% | 3812 |
|
|
2013
Q4 | $87K | Sell |
339
-1,517
| -82% | -$332K | ﹤0.01% | 4113 |
|
|
2013
Q3 | $271K | Buy |
1,856
+313
| +20% | +$37.8K | ﹤0.01% | 3929 |
|
|
2013
Q2 | $233K | Buy |
+1,543
| New | +$211K | ﹤0.01% | 3731 |
|
Other funds holding TXMD
RCMNY
E
GF
Deutsche Bank's TXMD Position: Q2 2022 in Review
Deutsche Bank sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 4,392 shares — an estimated $83K sold.
Deutsche Bank first reported a position in TXMD in Q2 2013 and held it in 36 quarters. The position peaked at $3.03M in Q3 2018. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.
- Deutsche Bank reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
- Deutsche Bank sold 4,392 TherapeuticsMD shares in Q2 2022, an estimated $83K.
- Deutsche Bank first reported a position in TherapeuticsMD in Q2 2013 and held it in 36 quarters.
- Deutsche Bank's TherapeuticsMD position peaked at $3.03M in Q3 2018.
- 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.
Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.